Retrophin - 48 Year Dividend Yield History | RTRX
Historical dividend payout and yield for Retrophin (RTRX) since 1971. The current TTM dividend payout for Retrophin (RTRX) as of February 15, 2019 is $0.00. The current dividend yield for Retrophin as of February 15, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Retrophin is a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases for which there are currently no viable options for patients. The Company's approved products include Chenodal?, Cholbam, and Thiola?, and its pipeline includes compounds for several catastrophic diseases, including focal segmental glomerulosclerosis, pantothenate kinase-associated neurodegeneration, infantile spasms, nephrotic syndrome and others. Retrophin, Inc. is based in San Diego.